Stanley Frankel insider trades

Open-market stock purchases and sales by Stanley Frankel, Director at Precision Biosciences Inc, from SEC Form 4 filings since Apr 12, 2021.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +35%.

Recent trades

DateStockTradeValue
Jun 3, 2026DTIL Precision Biosciences IncBought (not open market)—
May 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Dec 16, 2025DTIL Precision Biosciences IncBought$12.7K

Companies traded

  • DTIL Precision Biosciences Inc: 2 buys, last Jun 3, 2026

Get free alerts when Stanley Frankel files a new trade →